Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable, Shares

No definition available.

Name:	exas_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares
Namespace Prefix:	exas_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 50
-Section 30
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 50
-Section 30
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 50
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495

+ Details

Name:	us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of shares of equity interests issued or issuable to acquire entity.

+ References

+ Details

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AssetAcquisitionAxis=exas_TARDISTechnologyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=exas_OmicEraDiagnosticsAcquisitionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=exas_PreventionGeneticsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=exas_AshionAnalyticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=exas_ThriveEarlierDetectionCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($) shares in Millions, $ in Millions					1 Months Ended
	Dec. 31, 2021	Apr. 14, 2021	Jan. 11, 2021	Jan. 05, 2021	May 31, 2022	May 01, 2022
TARDIS technology
Subsidiary or Equity Method Investee [Line Items]
Payments to acquire productive assets (in shares)			0.2
Stock issued to acquire productive assets, value			$ 27.3
OmicEra diagnostics acquisition
Subsidiary or Equity Method Investee [Line Items]
Business acquisition, equity interest issued or issuable (in shares)					0.3
Fair value of stock issued in acquisition						$ 14.8
PreventionGenetics acquisition
Subsidiary or Equity Method Investee [Line Items]
Business acquisition, equity interest issued or issuable (in shares)	1.1
Fair value of stock issued in acquisition	$ 84.2
Ashion acquisition
Subsidiary or Equity Method Investee [Line Items]
Business acquisition, equity interest issued or issuable (in shares)		0.1
Fair value of stock issued in acquisition		$ 16.2
Thrive acquisition
Subsidiary or Equity Method Investee [Line Items]
Business acquisition, equity interest issued or issuable (in shares)				9.3
Fair value of stock issued in acquisition				$ 1,190.0